Compare KBR & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KBR | SHC |
|---|---|---|
| Founded | 1901 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | 2006 | 2020 |
| Metric | KBR | SHC |
|---|---|---|
| Price | $35.99 | $15.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $52.43 | $20.33 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | 15.05 | ★ 68.75 |
| EPS | ★ 3.21 | 0.27 |
| Revenue | ★ $5,767,000,000.00 | $1,163,617,000.00 |
| Revenue This Year | $4.56 | $7.51 |
| Revenue Next Year | $5.11 | $6.00 |
| P/E Ratio | ★ $11.21 | $57.59 |
| Revenue Growth | 2.27 | ★ 5.74 |
| 52 Week Low | $34.75 | $10.80 |
| 52 Week High | $56.78 | $19.85 |
| Indicator | KBR | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 50.79 |
| Support Level | $35.91 | $15.19 |
| Resistance Level | $38.34 | $16.55 |
| Average True Range (ATR) | 0.95 | 0.40 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 43.66 | 20.57 |
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.